Capsular Contracture: Understanding the Complication and Why Prevention Matters

Capsular contracture is a recognized complication after breast implant surgery in which the scar tissue (capsule) that naturally forms around an implant tightens or thickens, sometimes causing firmness, discomfort, or changes in breast shape. The U.S. Food and Drug Administration lists capsular contracture among the risks and complications associated with breast implants; patients should review those risks as part of informed decision-making (see FDA risks). Understanding what capsular contracture can look and feel like, how surgeons evaluate and manage it, and why no single technique eliminates the risk will help you ask informed questions at consultation.

For clinic context only: our team includes clinicians described as “Motiva Global KOL, 2024–2026 (3 consecutive years)” and “Motiva Asia-Pacific Instructor, 2026.” The clinic reports 3,000+ Motiva-registered breast augmentations and a 2,130-case ISAPS 2025 presentation as contextual experience; these figures are context, not proof of outcomes.

Learn about our surgeons and credentials • See procedures we offer • Common questions answered • Request a consultation • Pillar resource: Motiva Preservé in Korea: The Complete Guide.

What capsular contracture can cause (potential symptoms)

Capsular contracture presents variably. Some people have minimal symptoms and no functional concerns; others may notice:

  • Increased firmness or hardness of the breast
  • Tightening sensation or discomfort, particularly when pressing on the breast
  • Visible changes in breast shape, asymmetry, or elevation of the implant
  • Pain or tenderness in the affected breast

If you notice new firmness, pain, or shape changes after implant surgery, prompt clinical assessment is recommended. The FDA recommends discussing any new breast changes with your surgeon or a health professional experienced in breast implants (see FDA patient considerations).

How surgeons evaluate capsular contracture

Diagnosis typically begins with medical history and physical examination. Imaging (ultrasound, mammogram, or MRI) may be used to evaluate implant position, integrity, and surrounding tissue when clinically indicated. The decision to monitor, medically manage, or recommend surgery depends on symptom severity, degree of contracture, implant type, and patient goals.

Hearing your surgeon’s approach to evaluation is important. Useful consultation questions are below.


Considering breast augmentation? Book a personalized consultation with Dr. Sangmun Choi to discuss your goals and learn how the Preservé technique can work for you.


When is treatment considered?

Management is individualized. Options may include:

  • Observation and symptom monitoring if changes are mild and acceptable
  • Medical management for pain or inflammation when appropriate
  • Surgical revision in cases of moderate-to-severe contracture, recurrent contracture, implant rupture, or when symptoms or appearance are unacceptable to the patient

Surgical revision strategies vary and may include capsule release or capsulectomy, implant exchange, pocket change, or other adjuncts. Each option has trade-offs and may not eliminate the risk of recurrence.

Risk factors and why risk cannot be entirely eliminated

Multiple factors appear to influence capsular contracture risk. These can include surgical technique, implant characteristics, pocket placement, infection or subclinical inflammation, hematoma, and individual patient biology. No single factor accounts for every case.

Why no single technique or product removes all risk:

  • Biological variability: Wound healing and immune responses differ between individuals; that variation affects scar formation and capsule behavior.
  • Multifactorial causes: Because capsular contracture can result from several interacting factors, addressing only one element—such as implant surface or pocket irrigation—does not neutralize other contributors.
  • Evolving evidence: Surgical strategies and devices evolve; available guidance and data are continually updated. The International Society of Aesthetic Plastic Surgery provides procedural overviews and considerations for augmentation that highlight technique choices without implying complete risk elimination (see ISAPS breast augmentation guide).
  • Device-related factors: Implant design and material choices may influence tissue response. Manufacturers describe their product features and postmarket programs; review any product-specific information with your surgeon and by consulting manufacturer materials such as the Motiva implants overview and product warranty where relevant.

Because of these realities, risk-reduction aims to lower probability and severity rather than guarantee prevention. The FDA recommends patients consider these ongoing risks when deciding on implants and to discuss long-term follow-up plans with their surgeon (see FDA patient considerations).

Modern techniques and adjuncts — what they may address

Surgeons may combine multiple preventive measures during implantation to reduce factors associated with contracture. Commonly discussed strategies include careful sterile technique, minimizing implant handling, pocket irrigation, appropriate haemostasis, implant selection and placement, and postoperative care. Some device manufacturers and clinicians also report product-specific programs and warranties that relate to device integrity and follow-up; for example, see the Motiva implants overview and Motiva product warranty for details on their patient support programs.

Simple comparison: common preventive targets

Preventive focusExample techniques or considerations
Reduce contamination or bacterial burdenAtraumatic handling, pocket irrigation, limiting implant contacts (cite manufacturer/surgeon protocols)
Control bleeding and inflammationCareful haemostasis, avoiding hematoma formation
Implant choice and surfaceDiscussed by manufacturers; review product literature (Motiva implants overview)
Placement and pocket typeSurgeon’s judgement informed by anatomy and goals (see ISAPS breast augmentation guide)

Note: Table entries reference general strategies; consult your surgeon for how these are applied in your care and for product-specific information from manufacturers.

Management evaluation: questions to ask at consultation

Bring a list of questions to your consultation so you can compare approaches and make an informed choice. Suggested questions:

  1. How do you assess and classify capsular contracture severity? What would prompt observation versus revision surgery?
  2. Which surgical strategies do you use to reduce the risk of contracture, and what is the rationale for them in my case?
  3. How do you select implant type, surface, and pocket placement for my anatomy and goals? (Ask them to reference device literature if applicable, such as the Motiva implants overview.)
  4. What are the possible management options if I develop contracture later? What are the potential benefits and trade-offs of each?
  5. How is postoperative follow-up structured here, and what long-term monitoring do you recommend consistent with regulatory guidance (see FDA patient considerations)?
  6. If a device-specific issue arises, what manufacturer support or warranty programs are available? (Request product warranty details; for example, see Motiva product warranty.)
  7. What are the signs of early problems (e.g., firmness, pain, asymmetry) and when should I seek review?
  8. How will potential revision surgery affect recovery, scarring, and future options?

Asking about published guidance and device materials can help you see how a surgeon’s practice aligns with broader recommendations. For independent procedural context, the ISAPS breast augmentation guide covers a range of technique considerations and patient information (see ISAPS breast augmentation guide).

Shared decision-making and follow-up

Choosing breast implants and a surgical plan should be a shared decision that balances aesthetic goals with a clear understanding of potential complications and long-term follow-up needs. Consider:

  • Your values and willingness to accept the possibility of future procedures
  • A plan for postoperative monitoring and timely review of new symptoms
  • How implant-specific support programs or warranties may apply in different scenarios (see manufacturer information such as Motiva product warranty and Motiva implants overview)

If you proceed with augmentation, expect a recommended schedule for clinical reviews and to report new symptoms promptly. The FDA provides patient-facing considerations that underscore the importance of informed consent and ongoing follow-up (see FDA patient considerations).

Practical checklist before surgery

  • Review risks and complications with your surgeon (ensure they discuss FDA-listed risks).
  • Ask about the surgeon’s specific techniques to minimize contracture risk.
  • Request device-specific literature and warranty information if a particular implant is proposed (for example, Motiva informational materials).
  • Clarify follow-up timeline and who to contact for concerns after surgery.
  • Keep a personal record of implant details (device type, serial number, procedure date).

Unordered list of red-flag symptoms that usually warrant prompt review:

  • Rapid increase in firmness or sudden pain
  • Noticeable change in breast shape or implant position
  • Signs of infection (fever, redness, drainage)
  • Any new lumpiness or firmness accompanied by systemic symptoms

Final considerations

Capsular contracture is a recognized and sometimes persistent complication of breast implants. While many strategies aim to reduce its likelihood, no single technique or device eliminates risk for every person. Evaluating surgeon experience, technique philosophy, device information, and postoperative support will help you make an individualized plan. If you’d like to discuss options, book a consultation to review technique choices and follow-up plans tailored to your anatomy and priorities.

Further reading: Motiva Preservé in Korea: The Complete Guide

Sources

Sources

This article is for informational purposes only and is not medical advice. Individual suitability, recovery, and results vary.

Ryan Plastic Surgery Videos

"I've Heard Horror Stories" — Talking Honestly About Capsular Contracture